Comment: More Tales FromInstitutional Review Boards by Neuhauser, Duncan
Health Matrix: The Journal of Law-
Medicine
Volume 4 | Issue 1
1994
Comment: More Tales FromInstitutional Review
Boards
Duncan Neuhauser
Follow this and additional works at: https://scholarlycommons.law.case.edu/healthmatrix
Part of the Health Law and Policy Commons
This Featured is brought to you for free and open access by the Student Journals at Case Western Reserve University School of Law Scholarly
Commons. It has been accepted for inclusion in Health Matrix: The Journal of Law-Medicine by an authorized administrator of Case Western Reserve
University School of Law Scholarly Commons.
Recommended Citation
Duncan Neuhauser, Comment: More Tales FromInstitutional Review Boards, 4 Health Matrix 153 (1994)
Available at: https://scholarlycommons.law.case.edu/healthmatrix/vol4/iss1/12
Comment
MORE TALES FROM
INSTITUTIONAL REVIEW
BOARDS
Duncan Neuhausert
IN 1984, DR. BARRY MARSHALL came to the then outra-
geous and heretical conclusion that bacteria caused peptic ul-
cers.1 Because no one believed him, Dr. Marshall tested his
idea by swallowing a glass full of bacteria to see if he would
get an ulcer. If he did not get ill, he would prove himself
wrong. If he was right, he could become seriously ill.' Dr. Mar-
shall did not consult the hospital's ethics board, violating the
established hospital policy, because he thought the board would
disapprove of the experiment, calling it "too dangerous."' After
drinking the bacteria, he became ill, recovered and eventually
convinced the medical world that he was correct. This discov-
ery led to the publication of 1500 scientific papers worldwide,
an effective antibiotic treatment at a much lower cost than ex-
isting treatment, the probable future elimination of this disease
and a great reduction in stomach cancer mortality.4
The institutional review board ("IRB") could have turned
Dr. Marshall down, but the world would not have been better
off. If denied approval, Dr. Marshall could not appeal the deci-
sion. He would have had to move to another hospital and been
forced to try again.
t Professor of Epidemiology and Biostatistics at Case Western Reserve University
School of Medicine.
1. Terence Monmaney, Marshall's Hunch, NEW YORKER, Sept. 20, 1993, at 64, 64
(reviewing the struggle of Dr. Marshall to gain acceptance of his theory by the scientific
community and emphasizing the potential loss of innovative research had Dr. Marshall not
persevered).
2. Id.
3. Id.
4. Id. at 67.
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I wish to applaud the essay Tales of Informed Consent:
Four Years on an Institutional Review Board by "Bartolo." 5
IRB committees are required for hospitals receiving fed-
eral funds for research. Their role is to review research propos-
als to determine if informed consent and other safeguards, such
as confidentiality, are in place for the research carried out at
the institutions.6 All this sounds wonderful. However, in reality
there are serious problems that can turn these boards into petty
tyrannies causing more harm than good. Such problems include
no appeal procedure, no due process, negligible public account-
ability and no agreed upon accumulated body of precedents.7
In one hospital, a randomized trial was carried out where
some residents were paid money if they ordered fewer labora-
tory tests. 8 This trial showed that financial incentives had a
modest effect.' Another hospital proposed to replicate this
study. However, its IRB vehemently rejected the proposal, stat-
ing that it was unacceptable to "bribe doctors not to test."'1
Hence, one board's acceptable study is another IRB's outrage.
It is not uncommon to have studies accepted at one place
and not accepted at another. IRB's are established in hospitals
in the U.S. which have federal research grants." Community
hospitals not conducting such research may have no IRB's and
5. "Bartolo," Tales of Informed Consent: Four Years on an Institutional Review
Board, 2 HEALTH MATRIX 193 (1992) (documenting "Bartolo's" experience as a volunteer
attorney on the institutional review board of a hospital for a four-year period).
6. Id. at 194.
7. But cf. 21 C.F.R. 56.121(a) (1992) (providing that the Food and Drug Adminis-
tration act as a watchdog over an IRB, removing an IRB's qualifications if it fails to ob-
serve federal regulations or acts in a way which is detrimental to the rights of human
subjects).
8. Albert R. Martin et al., A Trial of Two Strategies to Modify the Test-Ordering
Behavior of Medical Residents, 303 NEw ENG J MED 1330, 1331 (1980). First year
residents were divided into three groups in order to evaluate the effect of different interven-
tions on test-ordering behavior. One group was the control group, one was offered financial
incentives if test-ordering was reduced and the third group was subjected to concurrent
chart review. Id.
9. Id. at 1332-33 (demonstrating reduction in test ordering in both the chart-review
and incentive groups with the chart-review having the most significant reduction and long-
lasting effect).
10. This information was relayed orally to the author from the President of the IRB
in this particular project study. The author requested that the name of the hospital and the
IRB President be kept confidential.
11. 21 C.F.R. 56.101(a) (1992) (established to "protect the rights and welfare of
human subjects involved in such investigations"); 21 C.F.R. 56.121(d) (1992) (stating that
a research grant will not be approved by the FDA if the review is conducted by an IRB or
institution which has lost its qualification).
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can therefore carry out research not federally funded without
the benefit of such review. For instance, regulating physician
behavior through finances or other means (as in the above
study) will only come before an IRB if it is declared a research
project - that is if one wished to learn whether a particular
alteration has the effect so desired. Unexamined change occurs
all the time in hospitals. A drug is tried on a patient just to see
if it works; thus, the line between therapy and experimentation
can become blurred. 12
Today, good management practice calls for empowering
employees of an organization by creating ways of improving
things, trying out the changes in small experiments, measuring
the results and adopting any beneficial change.' 3 This thinking
is imbedded in continuous quality improvement concepts which
are used in hospitals.1 4 So, what constitutes research? A nar-
row definition of research is a government research grant, while
a broad definition is any change examined to determine
whether it renders improvements. Apparently, change without
the desire to find out what positive effect it has need not be
reviewed by an IRB.
The following is an example where one hospital took steps
to improve an old practice. 5 At one time, regular nurses and
residents managed intravenous fluids ("IV's") for inpatients. It
was proposed that a specialized team be organized to manage
IV's. If this change had simply been made by management, no
12. Therapeutic experimentation, when used to treat the individual versus when con-
ducted for general research, is becoming more accepted as therapy. See George J. Annas,
Changing The Consent Rules For Desert Storm, 326 NEW ENG J MED 770, 772 (1993)
(discussing the approval of waiving informed consent to use experimental drugs on military
personnel during wartime); 21 C.F.R. 50.23(d)(1) (1992).
13. PETER M SENGE. THE FIFTH DISCIPLINE: THE ART AND PRACTICE OF THE
LEARNING ORGANIZATION 139-173 (1990) (emphasizing motivating the individual employ-
ees of an organization as the key to corporate growth, since it is the individuals who carry
the potential and energy).
14. See generally MARY WALTON. THE DEMING MANAGEMENT METHOD 136 (1986)
(exploring the concept of continuous quality improvement and focusing on the elements of
customer priority, employee involvement and uncompromising integrity); MARY WALTON.
DEMING MANAGEMENT AT WORK 83-117 (1990) (surveying nine hospitals committed to
continued improvement and quality transformation and revealing that the management at
these hospitals focused efforts towards teamwork); HARRY V. ROBERT & BERNARD F
SERGESKETTER. QUALITY IS PERSONAL, A FOUNDATION FOR TOTAL QUALITY MANAGE-
MENT 112-130 (1993) (identifying specific activities which can be implemented in order to
facilitate efficiency and employee satisfaction in health care organizations).
15. Although this example is taken from a published study, for the sake of anonym-
ity the author requests that no citation be provided.
19941
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IRB review would have been required. However, the hospital
decided to put the IV teams in place in one unit and not in a
another in order to compare rates of infection. This decision
needed IRB review, which was later obtained. The IRB consid-
ered the change in the management of IV's an administrative
change, and, therefore, individual informed consent was not re-
quired. This was because the treatments provided would not
change, but rather the change would occur in who was ad-
ministering the treatments. The study showed that the special-
ized teams were more effective. The results were published and
went unchallenged. 16 Several years later, in a round of budget
cuts, management decided to eliminate the IV teams. If they
had proposed a study of the elimination to learn the effects of
such actions, the IRB might well have declared the study un-
ethical. After all, there was clear evidence available that
showed that teams were better. The proposal would thus deny
patients demonstrably better care. Would you be willing to
have less skilled care? The IRB might well have demanded in-
dividualized consent. However, because management selected
worse care without labeling the change "research", the change
could be carried out without informing any patient or the IRB
review.
Thus we have a double standard of acceptable behavior.
Recommendations:
1) Recognize that the current system of review is seriously
flawed. We should be indebted to "Bartolo" for bringing
some of these problems forward.
2) Recognize that we do not have a good answer for the
review of research and allow a variety of alternatives to
exist so that they can be examined. 1 (Be assured that any
such proposed change, if you wish to see if it works, will be
declared unethical by at least some IRB members).
3) Require government funded patient-based research to
include the cost of insurance against harm. This would not
be unlike the flight insurance you can buy at an airport (so
16. For the same reasons stated in supra note 15, no cite is provided for this source.
17. See, e.g., A.M. Capron, Protection of Research Subjects: Do Special Rules Ap-
ply in Epidemiology?, 44 J CLINICAL EPIDEMIOLOGY 815 (1991), reprinted in 19 LAW.
MED & HEALTH CARE 184, 186-89 (1992) (proposing alternatives to informed consent,
such as peer consultants, after-the-fact debriefing and informed veto, which serve the same
functions of minimizing harm, improving research and promoting autonomy and self-
determination).
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much money if you loose an arm, etc.). The cost of this
insurance would vary with the level of risk of the study and
would, therefore, place a market based value on the poten-
tial sacrifice made by patients. This idea counters the
vested interest of the research establishment which appears
to want all the money to go to them and not be diverted to
patients. (This is not a slur, but a testable hypothesis, if
you could get it through an IRB).
4) Recognize that there are market solutions to this prob-
lem. This follows Milton Friedman's writings which oppose
all forms of professional licensure.18 One should not take
on a trivial example to show how a market alternative
might work.
One patient-based research study using sham operations
unbeknownst to the patients involved is often cited as one of
the worst American examples. 19 It was a trial of internal mam-
mary artery ligation to reduce the pain of angina versus sham
operations2 0 Without informing the patients in advance that
they were part of an experiment, an incision was made and a
random choice was taken to tie off the artery or do nothing.
The opening was sewed up and the patient woke up not know-
ing which decision was made.21 The result was that both groups
of patients felt less pain. The conclusion was drawn that this
surgery was ineffective. The blinding of patients and post-oper-
ative examiner was essential to providing this convincing re-
sult. 2 As a result, this procedure is no longer performed, pro-
tecting us from receiving this worthless procedure which was
once widely performed.
Let me propose that the real horror story here is that these
patients were never rewarded after the fact for their contribu-
tion to all our welfare. In today's medical care dollars, they
18. MILTON FRIEDMAN. CAPITALISM AND FREEDOM 137-160 (2d ed. 1982). Profes-
sional licensure acts as a means of limiting the number of professionals in a given field and
hence creates a monopoly. Id. at 151. Friedman argues that licensure counters an individ-
ual's right to voluntarily enter into a contract and further provides no means of quality
control. Id. at 147.
19. Ernest M. Barsamian, The Rise and Fall of Internal Mammary Artery Ligation
in the Treatment of Angina Pectoris and the Lessons Learned, in CosTs, RISKs. AND BEN-
EFITS OF SURGERY 212, 212-220 (John P. Bunker et al. eds., 1977) (noting that the out-
come of this study increased the favorability of controlled studies and in addition has
spurred scientists to question the reliability of standard testing procedures).
20. Id. at 216.
21. Id.
22. Id. at 217-18.
1994]
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might have saved half-a-billion dollars a year for our health
care system. Should each of those nine patients (that's all there
were in this study) receive say ten percent of the savings. Per-
haps they would receive about ten million dollars a year for the
rest of their lives.
A market alternative for a research hospital would be to
say that twenty percent of all patients will be experimented
upon and compensated handsomely for their social contribu-
tion. Possible participation is assumed on elective admission to
the hospital. Therefore, if the waiting list for admission is long,
the compensation may be too high. If the hospital becomes
empty, then compensation is too low.
I put this recommendation forward with no expectation
that anyone will rush to adopt it. Rather, I want to provoke
deeper thoughts about alternatives to the present flawed
approach.
